4
Changes in Ownership
Dyne Therapeutics, Inc. Filed Acc 0001209191-23-032279
Options or other derivatives
- Director acquired 24,900 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Rhodes Jason P Director | 2023-05-24 | Grant or award · Stock Option (right to buy) | +24,900 | 24,900 | D | ||
Loading xslF345X04/doc4.xml…